Order Article Reprints

Di Fusco M, Sun X, Anatale-Tardiff L, Yehoshua A, Coetzer H, Alvarez MB, Allen KE, Porter TM, Puzniak L, Lopez SMC, et al. Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy. Vaccines. 2023; 11(11):1669. https://doi.org/10.3390/vaccines11111669

Di Fusco, Manuela, Xiaowu Sun, Laura Anatale-Tardiff, Alon Yehoshua, Henriette Coetzer, Mary B. Alvarez, Kristen E. Allen, Thomas M. Porter, Laura Puzniak, Santiago M. C. Lopez, and et al. 2023. "Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy" Vaccines 11, no. 11: 1669. https://doi.org/10.3390/vaccines11111669

Di Fusco, M., Sun, X., Anatale-Tardiff, L., Yehoshua, A., Coetzer, H., Alvarez, M. B., Allen, K. E., Porter, T. M., Puzniak, L., Lopez, S. M. C., & Cappelleri, J. C. (2023). Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy. Vaccines, 11(11), 1669. https://doi.org/10.3390/vaccines11111669